Yang Yi,Liu Xin.Recent advances in the treatment of bladder/prostate rhabdomyosarcoma in children[J].Journal of Clinical Pediatric Surgery,2022,21(12):1101-1105.[doi:10.3760/cma.j.cn101785-202206005-001]
儿童膀胱/前列腺横纹肌肉瘤治疗进展
- Title:
- Recent advances in the treatment of bladder/prostate rhabdomyosarcoma in children
- Keywords:
- Rhabdomyosarcoma; Radiotherapy; Drug Therapy; Urogenital Surgical Procedures; Pathology; Surgical; Child
- 摘要:
- 横纹肌肉瘤是儿童和青年最常见的软组织肉瘤,其中膀胱/前列腺横纹肌肉瘤约占5%。经国际肿瘤协作组多年临床研究,不断更新治疗方案以及多学科协作综合治疗,儿童横纹肌肉瘤的整体存活率有所提高。然而,高风险横纹肌肉瘤的治疗进展缓慢。另外,在提高患儿存活率的前提下,如何减少近、远期并发症,提高患儿生活质量是临床急需解决的问题。由于国内各地区医疗水平的差异,我国儿童横纹肌肉瘤的总体存活率较国际水平仍然存在差距,为了提高小儿泌尿外科专业医师对该疾病的认识,本文就儿童膀胱/前列腺横纹肌肉瘤的治疗进展进行阐述。
- Abstract:
- Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children and young adults, with bladder/prostate rhabdomyosarcoma being identified in 5% of cases.The overall survival for children with RMS has improved over the last five decades with multi-modal treatment. However,little progress has been made in the treatment of high-risk group children,whose outcomes remain poor despite aggressive multimodal treatment. In addition,as more patients survive longer,how to improve the quality of life of children and reduce short-term and long-term complications are also clinical challenge to be faced. Due to the different levels of medical treatment in various regions,the overall survival rate of children with rhabdomyosarcoma in China is still different from the international standard. In order to improve the recognition of pediatric urologists on the disease,this article describes the progress in the treatment of bladder/prostate rhabdomyosarcoma in children.
参考文献/References:
[1] Rhee DS,Rodeberg DA,Baertschiger RM,et al.Update on pediatric rhabdomyosarcoma:a report from the APSA Cancer Committee[J].J Pediatr Surg,2020,55(10):1987-1995.DOI:10.1016/j.jpedsurg.2020.06.015.
[2] Saltzman AF,Cost NG.Current treatment of pediatric bladder and prostate rhabdomyosarcoma[J].Curr Urol Rep,2018,19(1):11.DOI:10.1007/s11934-018-0761-8.
[3] Hays DM,Raney RB,Wharam MD,et al.Children with vesical rhabdomyosarcoma (RMS) treated by partial cystectomy with neoadjuvant or adjuvant chemotherapy,with or without radiotherapy.A report from the Intergroup Rhabdomyosarcoma Study (IRS) Committee[J].J Pediatr Hematol Oncol,1995,17(1):46-52.DOI:10.1097/00043426-199502000-00008.
[4] Castagnetti M,Herbst KW,Esposito C.Current treatment of pediatric bladder and prostate rhabdomyosarcoma (bladder preserving vs.radical cystectomy)[J].Curr Opin Urol,2019,29(5):487-492.DOI:10.1097/MOU.0000000000000651.
[5] Rodeberg DA,Anderson JR,Arndt CA,et al.Comparison of outcomes based on treatment algorithms for rhabdomyosarcoma of the bladder/prostate:combined results from the Children’s Oncology Group,German Cooperative Soft Tissue Sarcoma Study,Italian Cooperative Group,and International Society of Pediatric Oncology Malignant Mesenchymal Tumors Committee[J].Int J Cancer,2011,128(5):1232-1239.DOI:10.1002/ijc.25444.
[6] Dantonello TM,Int-Veen C,Winkler P,et al.Initial patient characteristics can predict pattern and risk of relapse in localized rhabdomyosarcoma[J].J Clin Oncol,2008,26(3):406-413.DOI:10.1200/JCO.2007.12.2382.
[7] Chargari C,Haie-Meder C,Guérin F,et al.Brachytherapy combined with surgery for conservative treatment of children with bladder neck and/or prostate rhabdomyosarcoma[J].Int J Radiat Oncol Biol Phys,2017,98(2):352-359.DOI:10.1016/j.ijrobp.2017.02.026.
[8] Schmidt A,Warmann SW,Eckert F,et al.The role of reconstructive surgery and brachytherapy in pediatric bladder/prostate rhabdomyosarcoma[J].J Urol,2020,204(4):825-834.DOI:10.1097/JU.0000000000001127.
[9] Lobo S,Gaze MN,Slater O,et al.Bladder function after conservative surgery and high-dose rate brachytherapy for bladder-prostate rhabdomyosarcoma[J].Pediatr Blood Cancer,2022,69(8):e29574.DOI:10.1002/pbc.29574.
[10] Stenman J,Wickart-Johansson G,Sundquist F,et al.Five-year follow-up after multimodal treatment incorporating HDR brachytherapy for bladder prostate rhabdomyosarcoma in children[J].Int J Radiat Oncol Biol Phys,2022,113(2):355-359.DOI:10.1016/j.ijrobp.2022.01.034.
[11] Indelicato DJ,Rotondo RL,Krasin MJ,et al.Outcomes following proton therapy for group Ⅲ pelvic rhabdomyosarcoma[J].Int J Radiat Oncol Biol Phys,2020,106(5):968-976.DOI:10.1016/j.ijrobp.2019.12.036.
[12] Buszek SM,Ludmir EB,Grosshans DR,et al.Patterns of failure and toxicity profile following proton beam therapy for pediatric bladder and prostate rhabdomyosarcoma[J].Pediatr Blood Cancer,2019,66(11):e27952.DOI:10.1002/pbc.27952.
[13] Michalkiewicz EL,Rao BN,Gross E,et al.Complications of pelvic exenteration in children who have genitourinary rhabdomyosarcoma[J].J Pediatr Surg,1997,32(9):1277-1282.DOI:10.1016/s0022-3468(97)90301-8.
[14] Stein R,Frees S,Schr?der A,et al.Radical surgery and different types of urinary diversion in patients with rhabdomyosarcoma of bladder or prostate-a single institution experience[J].J Pediatr Urol,2013,9(6 Pt A):932-939.DOI:10.1016/j.jpurol.2013.01.008.
[15] Castagnetti M,Angelini L,Alaggio R,et al.Oncologic outcome and urinary function after radical cystectomy for rhabdomyosarcoma in children:role of the orthotopic ileal neobladder based on 15-year experience at a single center[J].J Urol,2014,191(6):1850-1855.DOI:10.1016/j.juro.2013.12.040.
[16] Rigamonti W,Iafrate M,Milani C,et al.Orthotopic continent urinary diversion after radical cystectomy in pediatric patients with genitourinary rhabdomyosarcoma[J].J Urol,2006,175(3):1092-1096.DOI:10.1016/S0022-5347(05)00401-5.
[17] Komasara L,Stefanowicz J,Bryks-Laszkowska A,et al.Reconstructive option after radical mutilating surgery in children with genitourinary rhabdomyosarcoma:when sparing the bladder is not an option[J].Int J Urol,2016,23(8):679-685.DOI:10.1111/iju.13120.
[18] 中华医学会小儿外科学分会泌尿学组.膀胱/前列腺横纹肌肉瘤专家共识[J].临床小儿外科杂志,2019,18(11):902-905,921.DOI:10.3969/j.issn.1671-6353.2019.11.002.Group of Urology,Branch of Pediatric Surgery,Chinese Medical Association.Bladder/Prostate Rhabdomyosarcoma Expert Consensus[J].J Clin Ped Sur,2019,18(11):902-905,921.DOI:10.3969/j.issn.1671-6353.2019.11.002.
[19] Merguerian PA,Cartwright L,Khoury AE.Genitourinary rhabdomyosarcoma and other bladder tumors[M]//Docimo SG,Austin P,Canning D,et al.The Kelalis-King-Belman Textbook of Clinical Pediatric Urology.6th Ed.London:CRC Press,2018:1000-1028.
[20] Ben Arush M,Minard-Colin V,Mosseri V,et al.Does aggressive local treatment have an impact on survival in children with metastatic rhabdomyosarcoma?[J].Eur J Cancer,2015,51(2):193-201.DOI:10.1016/j.ejca.2014.11.009.
[21] Mohan AC,Venkatramani R,Okcu MF,et al.Local therapy to distant metastatic sites in stage Ⅳ rhabdomyosarcoma[J].Pediatr Blood Cancer,2018,65(2):26859.DOI:10.1002/pbc.26859.
[22] Rodeberg D,Arndt C,Breneman J,et al.Characteristics and outcomes of rhabdomyosarcoma patients with isolated lung metastases from IRS-IV[J].J Pediatr Surg,2005,40(1):256-262.DOI:10.1016/j.jpedsurg.2004.09.045.
[23] Cameron AL,Elze MC,Casanova M,et al.The impact of radiation therapy in children and adolescents with metastatic rhabdomyosarcoma[J].Int J Radiat Oncol Biol Phys,2021,111(4):968-978.DOI:10.1016/j.ijrobp.2021.06.031.
相似文献/References:
[1]陆良生 肖现民. CD117蛋白在儿童横纹肌肉瘤中的表达[J].临床小儿外科杂志,2011,10(06):427.
[J].Journal of Clinical Pediatric Surgery,2011,10(12):427.
[2]彭丽,沈志鹏,王金湖.儿童横纹肌肉瘤脑转移1例及文献复习[J].临床小儿外科杂志,2023,22(11):1092.[doi:10.3760/cma.j.cn101785-202203037-018]
Peng Li,Shen Zhipeng,Wang Jinhu.Cerebral metastases of rhabdomyosarcoma in children:one case report with a literature review[J].Journal of Clinical Pediatric Surgery,2023,22(12):1092.[doi:10.3760/cma.j.cn101785-202203037-018]
备注/Memo
收稿日期:2022-6-4。
通讯作者:杨屹,Email:18940251106@163.com